A joint research team between the Center for Quantum Information and Quantum Biology (QIQB) at The University of Osaka and ...
Additional information about the 2026 AAN Annual Meeting is available at www.aan.com.
MEDIA ALERT]Flagship's early-stage companies to receive AWS cloud credits, technical support, and AI capabilities to ...
The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer’s Disease, or AI4AD. The new ...
BullFrog AI (BFRG) stock jumped 106% after announcing a drug discovery deal with a top-5 pharma firm targeting major ...
Phase 1b norovirus challenge study is underway at Emory University School of MedicineCDI-988 is the first oral antiviral ...
Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge ...
An international team of scientists proved the never-before-seen molecule's exotic nature using a quantum computer, ...
One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...
A collaboration “across multiple therapeutic areas” could net the Hong Kong-based biotech more than $2 billion as Lilly seeks ...
The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across ...
The Type C Meeting is part of a multidisciplinary strategy to seek alignment with the FDA on readiness to initiate a Phase 3 pivotal trial in MSA. Alterity received written feedback supporting its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results